Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Cagino K, Levitan D, Schatz-Siemers N, Zarnegar R, Chapman-Davis E, Holcomb K, et al. Multiple malignant transformations of an ovarian mature cystic teratoma. Ecancermedicalscience. 2020;14:1009.

Magro C, Cheng E, Kline MA, Belsito DV, Goldman B, Varghese M, et al. Follicular psoriasis: a report of 5 cases and review of the literature, likely an under-recognized yet distinctive variant of psoriasis. Dermatol Online J. 2020;26(7).

Westblade LF, Errington J, Dörr T. Antibiotic tolerance. PLoS Pathog. 2020;16(10):e1008892.

Jenkins S, Ledeboer NA, Westblade LF, Burnham CA, Faron ML, Bergman Y, et al. Evaluation of NG-Test Carba 5 for Rapid Phenotypic Detection and Differentiation of Five Common Carbapenemase Families: Results of a Multicenter Clinical Evaluation. J Clin Microbiol. 2020;58(7).

Kahn R, Zhou ZN, Goyal A, Gamble C, Nicholson N, Caputo TA, et al. Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix? Int J Gynecol Cancer. 2020;30(9):1298-1302.

Vossoughi S, Fischkoff K, DeSimone RA, Schwartz J. Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic. Transfusion. 2020;60(9):2156-2158.

G Park K, Lee JH, Soriano E, Choi M, Bao K, Katagiri W, et al. Rapid and Selective Targeting of Heterogeneous Pancreatic Neuroendocrine Tumors. iScience. 2020;23(4):101006.

Fulmer CG, Park K, Dilcher T, Ho M, Mirabelli S, Alperstein S, et al. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study. Cancer Cytopathol. 2020;128(11):840-851.

Chu Y-, Zhong W, Rehrauer W, Pavelec DM, Ong IM, Arjang D, et al. Clinicopathologic Characterization of Post-Renal Transplantation BK Polyomavirus-Associated Urothelial CarcinomaSingle Institutional Experience. Am J Clin Pathol. 2020;153(3):303-314.

Laurence J, J Mulvey J, Seshadri M, Racanelli A, Harp J, Schenck EJ, et al. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clin Immunol. 2020;219:108555.